Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses

September 11, 2020 | Radiomics

At HealthMyne we are passionate about improving cancer care through the powerful translation of radiomic insights into knowledge to inform cancer treatment and avoid unnecessary procedures. The field of radiomics is pioneering research that has critical impacts on cancer patients and their journey such as this study where radiomics is used to effectively discriminate benign from malignant renal masses.

Click here to read the full article >>